KING & SPALDING LLP

Lobbying for EGENESIS INC. · Gene editing platform for the development of transplantable organs.

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · Massachusetts · $10,000.00 income · posted Jan 19, 2026

Lobbying activity 1

Health Issues

Educate lawmakers on xenotransplantation.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem